Tel Aviv, Israel

Avital Laxer

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Tikva, IL (2014)
  • Tel Aviv, IL (2011 - 2016)

Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Avital Laxer: Innovator in Pharmaceutical Chemistry

Introduction

Avital Laxer is a prominent inventor based in Tel Aviv, Israel, known for her significant contributions to pharmaceutical chemistry. With a total of nine patents to her name, she has made remarkable strides in the development of innovative pharmaceutical compositions.

Latest Patents

Among her latest patents is the invention titled "N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide." This invention provides a pharmaceutical composition containing laquinimod or a pharmaceutically acceptable salt thereof, along with the compound N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide or a salt thereof. Another notable patent is focused on "Crystals of laquinimod sodium and improved process for the manufacture thereof," which details a mixture of crystalline laquinimod sodium particles with specific size requirements.

Career Highlights

Avital Laxer is currently associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her work has been instrumental in advancing the field of drug formulation and delivery.

Collaborations

Throughout her career, Avital has collaborated with esteemed colleagues such as Anton Frenkel and Eduard Gurevich, contributing to a dynamic research environment that fosters innovation.

Conclusion

Avital Laxer stands out as a key figure in pharmaceutical innovation, with her patents reflecting her dedication to improving healthcare solutions. Her contributions continue to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…